Speaker illustration

Associate Professor Leif Friberg

Friberg Research, Stockholm (Sweden)

Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation.

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Adverse outcomes in atrial fibrillation: can they be prevented?


Higher risk of dementia without oral anticoagulation in atrial fibrillation

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Anticoagulation in atrial fibrillation


A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records.

Event: ESC Congress 2017

Topic: Big data analysis in cardiology, registries and databases

Session: Big data


Major bleeding among patients with atrial fibrillation treated with rivaroxaban or warfarin in Sweden. Interim results from an on-going post-authorization study

Event: ESC Congress 2016

Topic: Medical treatment

Session: Are you still afraid about bleeding risk of antithrombotic therapy in atrial fibrillation?


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb